- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer Vaccines, Adjuvants, and Delivery Systems
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-03-30
DOI
10.3389/fimmu.2021.627932
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Peptide–TLR-7/8a conjugate vaccines chemically programmed for nanoparticle self-assembly enhance CD8 T-cell immunity to tumor antigens
- (2020) Geoffrey M. Lynn et al. NATURE BIOTECHNOLOGY
- Post-translational modifications such as citrullination are excellent targets for cancer therapy
- (2020) V.A. Brentville et al. SEMINARS IN IMMUNOLOGY
- MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
- (2020) Victor H Engelhard et al. Journal for ImmunoTherapy of Cancer
- An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
- (2020) Ugur Sahin et al. NATURE
- Combination vaccine based on citrullinated vimentin and enolase peptides induces potent CD4-mediated anti-tumor responses
- (2020) Victoria A Brentville et al. Journal for ImmunoTherapy of Cancer
- Ex vivo MRI cell tracking of autologous mesenchymal stromal cells in an ovine osteochondral defect model
- (2019) Hareklea Markides et al. Stem Cell Research & Therapy
- T cell repertoire to citrullinated self-peptides in healthy humans is not confined to the HLA-DR SE alleles; Targeting of citrullinated self-peptides presented by HLA-DP4 for tumour therapy
- (2019) Victoria A Brentville et al. OncoImmunology
- Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer
- (2019) James L. Gulley et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of HER2 after HER2-targeted treatment
- (2019) Tanja Ignatov et al. BREAST CANCER RESEARCH AND TREATMENT
- Long non-coding RNA PVT1 interacts with MYC and its downstream molecules to synergistically promote tumorigenesis
- (2019) Ke Jin et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Combination of CTLA-4 and PD-1 blockers for treatment of cancer
- (2019) Anand Rotte JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses
- (2019) Anthony E. Zamora et al. Science Translational Medicine
- Radiation therapy and anti-tumor immunity: exposing immunogenic mutations to the immune system
- (2019) Claire Lhuillier et al. Genome Medicine
- Highly versatile cell-penetrating peptide loaded scaffold for efficient and localised gene delivery to multiple cell types: From development to application in tissue engineering
- (2019) Rosanne M. Raftery et al. BIOMATERIALS
- Synthesis and Evaluation of Novel TLR2 Agonists as Potential Adjuvants for Cancer Vaccines
- (2019) Benjamin L. Lu et al. JOURNAL OF MEDICINAL CHEMISTRY
- An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders
- (2019) Mohammed Alghamdi et al. Journal of Immunology Research
- Toll-like Receptor Agonist Conjugation: A Chemical Perspective
- (2018) Bob J. Ignacio et al. BIOCONJUGATE CHEMISTRY
- A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy
- (2018) Xuexiang Du et al. CELL RESEARCH
- PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy
- (2018) Gizem Osman et al. JOURNAL OF CONTROLLED RELEASE
- LncRNAs regulate the cytoskeleton and related Rho/ROCK signaling in cancer metastasis
- (2018) Yanyan Tang et al. Molecular Cancer
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- A facile approach to enhance antigen response for personalized cancer vaccination
- (2018) Aileen Weiwei Li et al. NATURE MATERIALS
- Assessment of novel vaccination regimens using viral vectored liver stage malaria vaccines encoding ME-TRAP
- (2018) Carly M. Bliss et al. Scientific Reports
- Immunomodulatory vasoactive intestinal peptide amphiphile micelles
- (2018) Rui Zhang et al. Biomaterials Science
- Targeting gp100 and TRP-2 with a DNA vaccine: Incorporating T cell epitopes with a human IgG1 antibody induces potent T cell responses that are associated with favourable clinical outcome in a phase I/II trial
- (2018) Poulam M. Patel et al. OncoImmunology
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Discovery of peptide ligands targeting a specific ubiquitin-like domain–binding site in the deubiquitinase USP11
- (2018) Anastasios Spiliotopoulos et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Contribution of regulatory T cells to cancer: A review
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing
- (2018) Michael Bartoschek et al. Nature Communications
- Revised Overall Survival Analysis of a Phase II, Randomized, Double-Blind, Controlled Study of PROSTVAC in Men With Metastatic Castration-Resistant Prostate Cancer
- (2017) Philip W. Kantoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Identification of B and T cell epitope based peptide vaccine from IGF-1 receptor in breast cancer
- (2017) Manijeh Mahdavi et al. JOURNAL OF MOLECULAR GRAPHICS & MODELLING
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- Signalling strength determines proapoptotic functions of STING
- (2017) Muhammet F. Gulen et al. Nature Communications
- Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy
- (2017) Yihui Zhai et al. Theranostics
- Osteogenic Programming of Human Mesenchymal Stem Cells with Highly Efficient Intracellular Delivery of RUNX2
- (2017) Lalitha Thiagarajan et al. Stem Cells Translational Medicine
- Role of tumor microenvironment in tumorigenesis
- (2017) Maonan Wang et al. Journal of Cancer
- Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8 + T Cells
- (2017) Christopher D. Zahm et al. Cancer Immunology Research
- Corrigendum: Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
- (2017) Christina Gerstner et al. Frontiers in Immunology
- The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
- (2017) Terhi Karpanen et al. Frontiers in Immunology
- Citrullinated α-enolase is an effective target for anti-cancer immunity
- (2017) Katherine Cook et al. OncoImmunology
- HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance
- (2017) Barbara Seliger et al. OncoImmunology
- Highly efficient intracellular transduction in three-dimensional gradients for programming cell fate
- (2016) Hoda M. Eltaher et al. Acta Biomaterialia
- Nanotechnology inspired tools for mitochondrial dysfunction related diseases
- (2016) Ru Wen et al. ADVANCED DRUG DELIVERY REVIEWS
- Autophagy, citrullination and cancer
- (2016) Lindy G. Durrant et al. Autophagy
- Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines
- (2016) G. Bakdash et al. CANCER RESEARCH
- Regulatory T cells in cancer immunotherapy
- (2016) Atsushi Tanaka et al. CELL RESEARCH
- Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
- (2016) George A. Dominguez et al. CLINICAL CANCER RESEARCH
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Downregulation of the Deiminase PADI2 Is an Early Event in Colorectal Carcinogenesis and Indicates Poor Prognosis
- (2016) N. Cantarino et al. MOLECULAR CANCER RESEARCH
- Recent advances in liposome surface modification for oral drug delivery
- (2016) Thanh Xuan Nguyen et al. Nanomedicine
- Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
- (2016) Lena M. Kranz et al. NATURE
- Designer vaccine nanodiscs for personalized cancer immunotherapy
- (2016) Rui Kuai et al. NATURE MATERIALS
- DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy
- (2016) Angeliki Tiptiri-Kourpeti et al. PHARMACOLOGY & THERAPEUTICS
- Highly efficient delivery of functional cargoes by the synergistic effect of GAG binding motifs and cell-penetrating peptides
- (2016) James E. Dixon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immuno-pharmacodynamics for evaluating mechanism of action and developing immunotherapy combinations
- (2016) Ralph E. Parchment et al. SEMINARS IN ONCOLOGY
- SCIB1, a huIgG1 antibody DNA vaccination, combined with PD-1 blockade induced efficient therapy of poorly immunogenic tumors
- (2016) Wei Xue et al. Oncotarget
- TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patients
- (2016) Gijs G. Zom et al. Oncotarget
- Functional and Structural Characterization of a Novel HLA-DRB1*04:01-Restricted α-Enolase T Cell Epitope in Rheumatoid Arthritis
- (2016) Christina Gerstner et al. Frontiers in Immunology
- SCIB2, an antibody DNA vaccine encoding NY-ESO-1 epitopes, induces potent antitumor immunity which is further enhanced by checkpoint blockade
- (2016) Wei Xue et al. OncoImmunology
- Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
- (2016) Sophie Detienne et al. Scientific Reports
- Citrullinated Vimentin Presented on MHC-II in Tumor Cells Is a Target for CD4+ T-Cell-Mediated Antitumor Immunity
- (2015) V. A. Brentville et al. CANCER RESEARCH
- Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
- (2015) Michael S. Rooney et al. CELL
- Nonviral Oncogenic Antigens and the Inflammatory Signals Driving Early Cancer Development as Targets for Cancer Immunoprevention
- (2015) N. J. Chu et al. CLINICAL CANCER RESEARCH
- Vaccination with Melanoma Helper Peptides Induces Antibody Responses Associated with Improved Overall Survival
- (2015) C. M. Reed et al. CLINICAL CANCER RESEARCH
- Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation
- (2015) Erin Witalison et al. CURRENT DRUG TARGETS
- CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice
- (2015) Yunching Chen et al. HEPATOLOGY
- Therapeutic cancer vaccines
- (2015) Cornelis J.M. Melief et al. JOURNAL OF CLINICAL INVESTIGATION
- Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
- (2015) Melissa C. Hanson et al. JOURNAL OF CLINICAL INVESTIGATION
- Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway
- (2015) Qiao-Fen Fu et al. Journal of Hematology & Oncology
- Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs
- (2015) Rachid Ammi et al. PHARMACOLOGY & THERAPEUTICS
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- T cell exclusion, immune privilege, and the tumor microenvironment
- (2015) J. A. Joyce et al. SCIENCE
- Clonal status of actionable driver events and the timing of mutational processes in cancer evolution
- (2015) Nicholas McGranahan et al. Science Translational Medicine
- Targeting of surface alpha-enolase inhibits the invasiveness of pancreatic cancer cells
- (2015) Moitza Principe et al. Oncotarget
- Enolase-1 is a therapeutic target in endometrial carcinoma
- (2015) Mengyang Zhao et al. Oncotarget
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- DNA vaccines, electroporation and their applications in cancer treatment
- (2015) Si-Hyeong Lee et al. Human Vaccines & Immunotherapeutics
- A7RC peptide modified paclitaxel liposomes dually target breast cancer
- (2015) Jingyan Cao et al. Biomaterials Science
- Cancer vaccines
- (2015) L. H. Butterfield BMJ-British Medical Journal
- Vaccines Combined with Immune Checkpoint Antibodies Promote Cytotoxic T-cell Activity and Tumor Eradication
- (2015) O. A. Ali et al. Cancer Immunology Research
- Trial Watch: Peptide-based anticancer vaccines
- (2015) Jonathan Pol et al. OncoImmunology
- DNA vaccine for cancer immunotherapy
- (2015) Benjamin Yang et al. Human Vaccines & Immunotherapeutics
- ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
- (2014) Scott C. Bresler et al. CANCER CELL
- MHC-Restricted Phosphopeptides from Insulin Receptor Substrate-2 and CDC25b Offer Broad-Based Immunotherapeutic Agents for Cancer
- (2014) A. L. Zarling et al. CANCER RESEARCH
- Accumulation of Memory Precursor CD8 T Cells in Regressing Tumors following Combination Therapy with Vaccine and Anti-PD-1 Antibody
- (2014) L. Karyampudi et al. CANCER RESEARCH
- Carcinoembryonic antigen promotes colorectal cancer progression by targeting adherens junction complexes
- (2014) Olga Bajenova et al. EXPERIMENTAL CELL RESEARCH
- Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
- (2014) Gabor Valcz et al. JOURNAL OF CLINICAL PATHOLOGY
- Fibroblast heterogeneity in the cancer wound
- (2014) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Combination Therapy with Anti–CTLA-4 and Anti–PD-1 Leads to Distinct Immunologic Changes In Vivo
- (2014) Rituparna Das et al. JOURNAL OF IMMUNOLOGY
- Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
- (2014) Matthew M. Gubin et al. NATURE
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- Genomic architecture and evolution of clear cell renal cell carcinomas defined by multiregion sequencing
- (2014) Marco Gerlinger et al. NATURE GENETICS
- Self-assembly of peptides to nanostructures
- (2014) Dindyal Mandal et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Combined Stimulation of IL-2 and 4-1BB Receptors Augments the Antitumor Activity of E7 DNA Vaccines by Increasing Ag-Specific CTL Responses
- (2014) Ha Kim et al. PLoS One
- Unleashing the potential of NOD- and Toll-like agonists as vaccine adjuvants
- (2014) C. Maisonneuve et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Spatial and temporal diversity in genomic instability processes defines lung cancer evolution
- (2014) E. C. de Bruin et al. SCIENCE
- Disruption of CXCR2-Mediated MDSC Tumor Trafficking Enhances Anti-PD1 Efficacy
- (2014) S. L. Highfill et al. Science Translational Medicine
- Tamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivo
- (2014) M. H. Li et al. Journal of Materials Chemistry B
- Citrulline-Specific Th1 Cells Are Increased in Rheumatoid Arthritis and Their Frequency Is Influenced by Disease Duration and Therapy
- (2014) Eddie A. James et al. Arthritis & Rheumatology
- Efficient Induction of Antitumor Immunity by Synthetic Toll-like Receptor Ligand-Peptide Conjugates
- (2014) G. G. Zom et al. Cancer Immunology Research
- STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
- (2014) D. Chandra et al. Cancer Immunology Research
- Two in one: improving synthetic long peptide vaccines by combining antigen and adjuvant in one molecule
- (2014) Gijs G Zom et al. OncoImmunology
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
- (2013) Christiane Meyer et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Agonistic CD40 Antibodies and Cancer Therapy
- (2013) R. H. Vonderheide et al. CLINICAL CANCER RESEARCH
- Novel prostate acid phosphatase-based peptide vaccination strategy induces antigen-specific T-cell responses and limits tumour growth in mice
- (2013) Jaimy M. S. Saif et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Myeloid-derived suppressor cells in cancer: recent progress and prospects
- (2013) Yazan S Khaled et al. IMMUNOLOGY AND CELL BIOLOGY
- Transfection efficiency and transgene expression kinetics of mRNA delivered in naked and nanoparticle format
- (2013) Kyle K.L. Phua et al. JOURNAL OF CONTROLLED RELEASE
- Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
- (2013) Tyler R. Simpson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia
- (2013) Eric Tran et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- Engineering synthetic vaccines using cues from natural immunity
- (2013) Darrell J. Irvine et al. NATURE MATERIALS
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Highly Recurrent TERT Promoter Mutations in Human Melanoma
- (2013) F. W. Huang et al. SCIENCE
- MHC Class I-Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia
- (2013) M. Cobbold et al. Science Translational Medicine
- ‘Cancer associated fibroblasts’ – more than meets the eye
- (2013) Shalom Madar et al. TRENDS IN MOLECULAR MEDICINE
- Emerging Co-signaling Networks in T Cell Immune Regulation
- (2013) Keunok Jung et al. Immune Network
- Recombinant vaccines and the development of new vaccine strategies
- (2012) I.P. Nascimento et al. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
- BiVax: a peptide/poly-IC subunit vaccine that mimics an acute infection elicits vast and effective anti-tumor CD8 T-cell responses
- (2012) Hyun-Il Cho et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MUC1 Vaccine for Individuals with Advanced Adenoma of the Colon: A Cancer Immunoprevention Feasibility Study
- (2012) T. Kimura et al. Cancer Prevention Research
- Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting
- (2012) Hirokazu Matsushita et al. NATURE
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity
- (2012) Martin Kreutz et al. PLoS One
- High Avidity Cytotoxic T Lymphocytes Can Be Selected into the Memory Pool but They Are Exquisitely Sensitive to Functional Impairment
- (2012) Victoria A. Brentville et al. PLoS One
- Strategies to Use Immune Modulators in Therapeutic Vaccines Against Cancer
- (2012) Jay A. Berzofsky et al. SEMINARS IN ONCOLOGY
- Identification and functional characterization of T cells reactive to citrullinated vimentin in HLA-DRB1*0401-positive humanized mice and rheumatoid arthritis patients
- (2011) Omri Snir et al. ARTHRITIS AND RHEUMATISM
- Receptor Tyrosine Kinases and TLR/IL1Rs Unexpectedly Activate Myeloid Cell PI3Kγ, A Single Convergent Point Promoting Tumor Inflammation and Progression
- (2011) Michael C. Schmid et al. CANCER CELL
- Viral Vector-Based Therapeutic Cancer Vaccines
- (2011) Cecilia Larocca et al. CANCER JOURNAL
- The Present and Future of Peptide Vaccines for Cancer
- (2011) Craig L. Slingluff CANCER JOURNAL
- MHC Class I-Presented Tumor Antigens Identified in Ovarian Cancer by Immunoproteomic Analysis Are Targets for T-Cell Responses against Breast and Ovarian Cancer
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- Strategies to target molecules that control the acquisition of a mesenchymal-like phenotype by carcinoma cells
- (2011) Claudia Palena et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Autophagy in antigen-presenting cells results in presentation of citrullinated peptides to CD4 T cells
- (2011) Jamie M. Ireland et al. JOURNAL OF EXPERIMENTAL MEDICINE
- In Vitroandin VivomRNA Delivery Using Lipid-Enveloped pH-Responsive Polymer Nanoparticles
- (2011) Xingfang Su et al. MOLECULAR PHARMACEUTICS
- Self-assembly of peptide amphiphiles: From molecules to nanostructures to biomaterials
- (2010) Honggang Cui et al. BIOPOLYMERS
- Electroporation for DNA immunization: clinical application
- (2010) Sylvia van Drunen Littel-van den Hurk et al. Expert Review of Vaccines
- DNA Vaccines: Developing New Strategies against Cancer
- (2010) Daniela Fioretti et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
- (2010) John H. Sampson et al. JOURNAL OF CLINICAL ONCOLOGY
- Antibodies designed as effective cancer vaccines
- (2010) R. L. Metheringham et al. mAbs
- Intradermal Vaccinations With RNA Coding for TAA Generate CD8+ and CD4+ Immune Responses and Induce Clinical Benefit in Vaccinated Patients
- (2010) Susanne M Rittig et al. MOLECULAR THERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune responses against a liver-stage malaria antigen induced by simian adenoviral vector AdCh63 and MVA prime–boost immunisation in non-human primates
- (2010) Stefania Capone et al. VACCINE
- Identification of citrullinated vimentin peptides as T cell epitopes in HLAâDR4âpositive patients with rheumatoid arthritis
- (2009) Anouk L. Feitsma et al. ARTHRITIS AND RHEUMATISM
- Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice
- (2009) Sean O. Ryan et al. BIOLOGICAL CHEMISTRY
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- DNA vaccination with T-cell epitopes encoded within Ab molecules induces high-avidity anti-tumor CD8+T cells
- (2009) Victoria A. Pudney et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Partial protection against SIV challenge by vaccination of adenovirus and MVA vectors in rhesus monkeys
- (2009) H-B Wang et al. GENE THERAPY
- An integrated humoral and cellular response is elicited in pancreatic cancer by α-enolase, a novel pancreatic ductal adenocarcinoma-associated antigen
- (2009) Paola Cappello et al. INTERNATIONAL JOURNAL OF CANCER
- IFN- Enhances Peptide Vaccine-Induced CD8+ T Cell Numbers, Effector Function, and Antitumor Activity
- (2009) A. G. Sikora et al. JOURNAL OF IMMUNOLOGY
- Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients
- (2009) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Vaccination against HPV-16 Oncoproteins for Vulvar Intraepithelial Neoplasia
- (2009) Gemma G. Kenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery
- (2009) Mei Lin Tan et al. PEPTIDES
- Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment
- (2009) Anna-Karin Roos et al. PLoS One
- Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy
- (2009) F. R. Depontieu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A self-assembling peptide acting as an immune adjuvant
- (2009) J. S. Rudra et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies
- (2009) Kimberly A. Chianese-Bullock et al. VACCINE
- Multiple innate signaling pathways cooperate with CD40 to induce potent, CD70-dependent cellular immunity
- (2009) Jennifer A. McWilliams et al. VACCINE
- Antibodies to citrullinated α-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase
- (2008) Karin Lundberg et al. ARTHRITIS AND RHEUMATISM
- Abrogation of TGFβ Signaling in Mammary Carcinomas Recruits Gr-1+CD11b+ Myeloid Cells that Promote Metastasis
- (2008) Li Yang et al. CANCER CELL
- Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration
- (2008) Pieranna Chiarella et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA
- (2008) Benjamin Weide et al. JOURNAL OF IMMUNOTHERAPY
- Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma
- (2008) Isabelle Janoueix-Lerosey et al. NATURE
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started